Publicacións en colaboración con investigadores/as de Universidad Europea de Madrid (10)

2025

  1. Current status of the immunogenicity of enzyme replacement therapy in fabry disease

    Orphanet Journal of Rare Diseases , Vol. 20, Núm. 1

  2. Evaluation of carbohydrate antigen 125 in heart failure with preserved ejection fraction diagnosis

    Heart

  3. Novel approaches for the discovery of pharmacogenetic biomarkers of chemotoxicity in patients with colorectal cancer

    British Journal of Pharmacology, Vol. 182, Núm. 21, pp. 5340-5354

2024

  1. Worldwide distribution of genetic factors related to severity of COVID-19 infection

    Annals of Human Biology, Vol. 51, Núm. 1

2023

  1. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  2. Coronary Artery Disease and Prognosis of Heart Failure with Reduced Ejection Fraction

    Journal of Clinical Medicine, Vol. 12, Núm. 8

2021

  1. Ischemic etiology and prognosis in men and women with acute heart failure

    Journal of Clinical Medicine, Vol. 10, Núm. 8

  2. Prognostic impact of hyponatraemia and hypernatraemia at admission and discharge in heart failure patients with preserved, mid-range and reduced ejection fraction

    Internal Medicine Journal, Vol. 51, Núm. 6, pp. 930-938

2019

  1. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction

    Internal Medicine Journal, Vol. 49, Núm. 12, pp. 1505-1513

2018

  1. Influence of sex and pregnancy on survival in patients admitted with heart failure: Data from a prospective multicenter registry

    Clinical Cardiology, Vol. 41, Núm. 7, pp. 924-930